Cited by 69Diabetes Management and ResearchMobile Health and mHealth ApplicationsDiabetes Management and Education

Interactive Diary for Diabetes: A Useful and Easy-to-Use New Telemedicine System to Support the Decision-Making Process in Type 1 Diabetes

Rossi, Maria C.E., Nicolucci, Antonio, Pellegrini, Fabio, Bruttomesso, Daniela, Bartolo, Paolo Di, Marelli, Giuseppe, Dal Pos, Michela, Galetta, Marianna +2 more·2009·Diabetes Technology & Therapeutics

Abstract

BACKGROUND: Widespread use of carbohydrate (CHO) counting is limited by its complex educational needs, but a telemedicine system could simplify the patients' training. METHODS: The Diabetes Interactive Diary (DID) was set up on patients' mobile phones and allowed to record the blood glucose values and quantify the total CHO intake during a meal, by choosing the specific food and the amount ingested from a list of pictures. It also suggested the most appropriate insulin bolus in relation to the patient's CHO/insulin ratio. Data were sent to the physician by Short Message Service (also known as text message). Two pilot studies were carried out to investigate the feasibility and acceptability of the system and its effectiveness in improving metabolic control. RESULTS: In the first study, 50 patients were involved in a survey with questionnaires administered before and 12 weeks after the start of the DID. The system was considered by almost all the patients as easy to use and very helpful. CHO counting and insulin bolus calculation were ranked as the most useful functions. In the second study, 41 consecutive patients using DID under routine clinical practice conditions were evaluated after a median of 9 months of follow-up. DID was associated with a nonstatistically significant reduction in fasting blood glucose (FBG), postprandial glucose (PPG), and hemoglobin A1c levels. FBG and PPG coefficient of variation (CV) values were significantly reduced: FBG-CV decreased by 6.7% (95% confidence interval -11.9, -1.6; P = 0.02), while PPG-CV decreased by 11.5% (95% confidence interval -19.3, -3.7; P = 0.01). No patients reported serious hypoglycemic episodes requiring medical intervention. CONCLUSIONS: DID can represent a useful, safe, and easy-to-use tool to help the patient with type 1 diabetes promote dietary freedom. Adjustment of insulin doses according to CHO intake allowed the reduction of glucose variability, increasingly recognized as an important, independent risk factor for cardiovascular events.

Integrity signals

Registry

Crossref · 10.1089/dia.2008.0020

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rossi, M. C. E., Nicolucci, A., Pellegrini, F., Bruttomesso, D., Bartolo, P. D., Marelli, G., Dal Pos, M., Galetta, M., Horwitz, D., & Vespasiani, G.
Affiliations
  • Mario Negri Sud Foundation (IT)
  • Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbarco (CH), Italy.
  • University of Padua (IT)
  • Ospedale "Santa Maria delle Croci" di Ravenna (IT)
  • Azienda Ospedaliera di Desio e Vimercate (IT)
  • Dipartimento di Medicina Clinica e Sperimentale, Policlinico Universitario, Padova, Italy.
  • Servizio di Diabetologia, Ospedale Madonna del Soccorso, San Benedetto del Tronto (AP), Italy.
  • Medical & Clinical Affairs, LifeScan, Inc., Milpitas, California.
Venue
Diabetes Technology & Therapeutics
Published
2009-01
Volume
11
Issue
1
Pages
19-24
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W2093460604
Cited by
69
References
28
Citations by year
2026: 3 · 2024: 1 · 2023: 3 · 2022: 3 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 6 · 2016: 10 · 2015: 4 · 2014: 6 · 2013: 5 · 2012: 4
FWCI
4.84
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Technology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 1 diabetes, carbohydrate counting, mobile application, telemedicine, glycemic variability, blood glucose monitoring, HbA1c, insulin dose adjustment, hypoglycemia, patient acceptability
MeSH terms
Adult, Diabetes Mellitus, Type 1, Dietary Carbohydrates, Female, Humans, Insulin, Male, Patient Education as Topic, Surveys and Questionnaires, Self Care, Telemedicine, Monitoring, Ambulatory, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review